Skip to main content
Clinical Trials/NL-OMON32306
NL-OMON32306
Not yet recruiting
Not Applicable

24-Hour ambulatory blood pressure monitoring in patients with malignancies enrolled in phase I oncological studies - ABPM in patients with malignancies

Slotervaartziekenhuis0 sites15 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
cancer / hypertensie
Sponsor
Slotervaartziekenhuis
Enrollment
15
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Sponsor
Slotervaartziekenhuis

Eligibility Criteria

Inclusion Criteria

  • \- enrolled in ongoing or future phase I studies of novel anti\-cancer agents at the NKI\-AVL
  • \- scheduled to be hospitalized for at least a 24 hours during the phase I trial

Exclusion Criteria

  • \- currently associated with essential hypertension, cardiovascular disease or renal impairment
  • \- currently treated with drugs that are known to have an effect on the cardiovascular and/or the renovascular system

Outcomes

Primary Outcomes

Not specified

Similar Trials